KRS Global Biotechnology
KRS is an industry leading 503b Outsourcing Facility that provides sterile and non-sterile compounding services to patients, surgery centers, ophthalmology clinics and hospitals nationwide. KRS is committed to staying the unsurpassed provider of sterile intravenous admixture compounding services and to developing quality processes that facilitates the highest level of safety for patients who are recipients of intravenous, parenteral, enteral or oral preparations. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program focusing on strict compliance with current Good Manufacturing Practices (cGMP) and U.S. Pharmacopeia Guidelines standards. KRS commits to quality by design, compliance with FDA guidelines, upholding the highest ethical standards in the industry, and supports the best clinical care and patient safety in the industry.